Neuropilins in physiological and pathological angiogenesis

被引:194
作者
Staton, C. A. [1 ]
Kumar, I. [1 ]
Reed, M. W. R. [1 ]
Brown, N. J. [1 ]
机构
[1] Univ Sheffield, Acad Unit Surg Oncol, Microcirculat Res Grp, Sheffield S10 2JF, S Yorkshire, England
关键词
angiogenesis; neuropilins; VEGF; semaphorins; endothelial cells; lymphangiogenesis;
D O I
10.1002/path.2182
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuropilin-1 (Np1) and neuropilin-2 (Np2) are transmembrane glycoproteins with large extracellular domains that interact with both class 3 semaphorins and vascular endothelial growth factor (VEGF), and are involved in the regulation of many physiological pathways, including angiogenesis. The neuropilins also interact directly with the classical receptors for VEGF, VEGF-R1 and -R2, mediating signal transduction. The heart, glomeruli and osteoblasts express both Np1 and Np2, but there is differential expression in the adult vasculature, with Np1 expressed mainly by arterial endothelium, whereas Np2 is only expressed by venous and lymphatic endothelium. Both neuropilins are commonly over-expressed in regions of physiological (wound-healing) and pathological (tumour) angiogenesis, but the signal transduction pathways, neuropilin-mediated gene expression and the definitive role of neuropilins in angiogenic processes are not fully characterized. This review details the current evidence for the role of neuropilins in Angiogenesis, and suggests future research directions that may enhance our understanding of the mechanisms of action of this unique family of proteins. Copyright (c) 2007 Pathological Society of Great Britain and Ireland.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 132 条
[1]   Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells [J].
Akagi, M ;
Kawaguchi, M ;
Liu, W ;
McCarty, MF ;
Takeda, A ;
Fan, F ;
Stoeltzing, O ;
Parikh, AA ;
Jung, YD ;
Bucana, CD ;
Mansfield, PF ;
Hicklin, DJ ;
Ellis, LM .
BRITISH JOURNAL OF CANCER, 2003, 88 (05) :796-802
[2]  
Bachelder RE, 2003, CANCER RES, V63, P5230
[3]  
Banerjee SK, 2000, INT J ONCOL, V16, P253
[4]   The Role of Vascular Endothelial Growth Factor in Wound Healing [J].
Bao, Philip ;
Kodra, Arber ;
Tomic-Canic, Marjana ;
Golinko, Michael S. ;
Ehrlich, H. Paul ;
Brem, Harold .
JOURNAL OF SURGICAL RESEARCH, 2009, 153 (02) :347-358
[5]  
Bates DO, 2002, CANCER RES, V62, P4123
[6]   Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype [J].
Bielenberg, DR ;
Hida, Y ;
Shimizu, A ;
Kaipainen, A ;
Kreuter, M ;
Kim, CC ;
Klagsbrun, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) :1260-1271
[7]   Semaphorin SEMA3F localization in malignant human lung and cell lines - A suggested role in cell adhesion and cell migration [J].
Brambilla, E ;
Constantin, B ;
Drabkin, H ;
Roche, J .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :939-950
[8]   Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors [J].
Broholm, H ;
Laursen, H .
APMIS, 2004, 112 (4-5) :257-263
[9]   Angiogenesis induction and regression in human surgical wounds [J].
Brown, NJ ;
Smyth, EAE ;
Cross, SS ;
Reed, MWR .
WOUND REPAIR AND REGENERATION, 2002, 10 (04) :245-251
[10]   A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia [J].
Brusselmans, K ;
Bono, F ;
Collen, D ;
Herbert, JM ;
Carmeliet, P ;
Dewerchin, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3493-3499